Protective effect and its underlying mechanism of exenatide on human umbilical vein endothelial cell oxidative damage induced by homocysteine

MA Shi-feng,HONG Tian-pei,WEI Rui
DOI: https://doi.org/10.3969/j.issn.1006-6187.2013.04.017
2013-01-01
Abstract:Objective To investigate the protective effect of exenatide on the endothelial cell oxidative damage induced by homocysteine(Hcy) and to explore its underlying mechanism.Methods The in-vitro isolated human umbilical vein endothelial cells(HUVECs) were pre-incubated with exenatide for 1 h and then incubated with Hcy,exenatide and/or exendin(9-39) for 24 h.A confocal laser scanning microscope was used to detect the levels of intracellular reactive oxygen species(ROS) and nitric oxide(NO).The expression of endothelial nitric oxide synthase(eNOS) and phosphorylated eNOS(p-eNOS,Ser1177) was detected by Western blot.Results Compared with the control group,the intracellular level of ROS was increased by 54% and the intracellular level of NO was reduced by 34% in the Hcy-treated group(both P<0.05).Exenatide not only significantly reversed the increment of ROS generation and the reduction of NO production induced by Hcy treatment,but also dose-dependently upregulated the expression of p-eNOS.The above effects of exenatide were partly abolished by adding the glucagon-like peptide-1(GLP-1) receptor antagonist exendin(9-39).Conclusion Exenatide activates the phosphorylation of eNOS and therefore has protective effect on the vascular endothelial cell oxidative damage induced by Hcy.All these effects of exenatide are at least in part dependent on GLP-1 receptor.
What problem does this paper attempt to address?